- Status:
- Red
- Decision Date:
- February 2020
Comments
RED: NICE TA617 - for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure.
Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
- 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
- 4: Specifically designated as “hospital only” by product licence or by DH/NICE
search again